Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
February 23, 2023 04:00 ET
|
AKAMPION
- Leading European T cell therapy researcher adds further scientific expertise ROTTERDAM, February 23, 2023 - Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery...
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
January 17, 2023 04:00 ET
|
AKAMPION
- Strengthening of T cell research expertise to develop next-generation T cell therapies for patients with limited or no treatment options ROTTERDAM, January 17, 2023 - Pan Cancer T B.V., a...
Chimeric Antigen Receptor CAR T Cell Therapy Cancer Treatment Market Size Report
June 25, 2022 02:34 ET
|
KuicK Research
Singapore, June 25, 2022 (GLOBE NEWSWIRE) -- Global CAR T Cell Therapy Market & Clinical Trials Insight 2028 Report Highlights: Research MethodologyGlobal CAR T Cell Therapy Market Opportunity...
INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
June 16, 2022 09:00 ET
|
Invectys, Inc.
HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between...